Status:

WITHDRAWN

Corticosteroids for COVID-19

Lead Sponsor:

University of Alberta

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This trial is an interventional, randomized, placebo-controlled, adaptive clinical trial in outpatients with symptomatic microbiologically-confirmed SARS-CoV-2, in stable clinical condition, and incre...

Detailed Description

The proposed trial is an interventional, randomized, placebo-controlled, adaptive clinical trial in outpatients with symptomatic microbiologically-confirmed SARS-CoV-2, in stable clinical condition, a...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years.
  • Microbiologically-confirmed SARS-CoV-2.
  • Clinical symptoms compatible with COVID-19 for 14 days or less before randomization.
  • Oxygen saturation ≥ 95%.
  • Protein C-reactive in blood performed by point-of-care testing ≥ 20 mg/L.
  • Signed informed consent.

Exclusion

  • Oxygen requirement at home due to chronic lung disease.
  • Patients with immunosuppression or immunosuppressive therapies defined as:
  • Cancer on active chemotherapy.
  • Stem cell transplant in the previous 6 months.
  • Neutrophil count \< 1000 cells/mm3.
  • Chronic treatment with immunosuppressive therapy, except for low-dose (≤10 mg daily) prednisone or equivalent dose of other corticosteroids.
  • HIV-infected patients with CD4 \< 200 x 106/L.
  • Diagnosis with primary immunodeficiencies.
  • Chronic liver damage Child-Pugh C.
  • Chronic underlying process with suspected life expectancy less than 12 weeks.
  • Uncontrolled diabetes mellitus at screening, defined as no blood glucose testing or any blood glucose level higher than 14 mmol/L (or 250 mg/dL) in the last 14 days.
  • Diagnosis of any form of psychosis without receiving appropriate treatment.
  • Pregnancy at time of randomization.

Key Trial Info

Start Date :

August 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04795583

Start Date

August 1 2021

End Date

August 1 2022

Last Update

April 14 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Clinica de la Mujer

Bogotá, Colombia

2

ABC Medical Center

Mexico City, Mexico